Health and Human Services Secretary Robert F. Kennedy Jr. remains a central figure in the Trump administration’s efforts to address vaccine safety and autism concerns, despite internal tensions and skepticism from the broader scientific community.
Kennedy, seen by some in the Department of Health and Human Services (HHS) as the “ideas guy,” continues to lead the administration’s push on issues related to childhood vaccinations, particularly their alleged connection to autism. While President Donald Trump has long questioned the safety of certain vaccines, he has increasingly turned to Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services, for health policy advice. Oz, viewed by lobbyists and HHS insiders as a likely successor to Kennedy, frequently communicates with Trump on various health matters beyond his agency’s typical scope and is regarded as a key figure in delivering the president’s priorities.
In recent months, rumors surfaced suggesting Kennedy might resign and that Oz would lead a transition team at HHS; however, both Kennedy and Oz publicly denied these reports. Kennedy’s son also vocally rejected claims that his father would leave the post, underscoring the secretary’s intent to remain in office, potentially beyond the current administration. Still, internal evaluations of HHS management prompted a reorganization last winter, including reassignment of top officials and a greater operational role for Chris Klomp, the Medicare chief nominated for deputy secretary, who works closely with Kennedy.
The administration’s vaccine-related policies have stirred controversy, particularly Trump’s focus on reducing childhood vaccine requirements. The federal proposal aimed to cut vaccinations recommended for children from 17 diseases to 11 but was blocked by a federal judge citing procedural flaws and questions about the advisory panel’s appointment. The government is currently appealing the ruling.
Trump’s skepticism centers mainly on the measles, mumps, and rubella (MMR) vaccine. He has expressed interest in separating combined vaccines into individual shots, despite scientific consensus that combination vaccines are safe, effective, and help prevent missed doses. Multiple large-scale studies, including research involving more than 600,000 children in Denmark and comprehensive reviews of existing literature, have found no credible link between the MMR vaccine and autism. Leading researchers emphasize that current vaccines contain fewer antigens and are designed to stimulate the immune system efficiently with reduced risk.
Autism spectrum disorder diagnoses in the United States have risen over the past two decades, with the Centers for Disease Control and Prevention estimating about one in 31 children were affected in 2022, up from about one in 150 in 2000. Scientists point to factors such as genetics, increased parental age, and improved diagnostic methods as likely contributors to the increase, though definitive causes remain unidentified.
The Trump administration maintains it is committed to addressing parental concerns through “gold-standard science.” White House and HHS spokespeople have emphasized alignment between the president and Kennedy on confronting what they describe as a chronic disease epidemic among children. In June, Kennedy petitioned an appeals court for expedited consideration of vaccine-related autism claims.
While Kennedy’s broader policy agenda, referred to within parts of the administration as the “Make America Healthy Again” (MAHA) movement, has seen mixed results, he has secured voluntary industry commitments to reduce food dyes and influenced new dietary guidelines promoting whole foods. However, efforts to eliminate certain pesticides and additives have encountered delays and criticism due to potential cost increases.
The department faces other challenges, including disputes with states over Medicaid fraud allegations, staffing shortages, a significant rise in measles cases not seen in three decades, and an expanding outbreak of cyclosporiasis.
Despite divergences within the administration and scientific community, Kennedy maintains a warm relationship with President Trump, who has publicly praised the secretary. Yet, political pressures persist as the administration navigates the complex intersection of public health policy, scientific evidence, and vocal advocacy regarding vaccines and autism.